Cloning and characterization of rat casein kinase 1ϵ  by Takano, Atsuko et al.
Cloning and characterization of rat casein kinase 1O
Atsuko Takanoa;*, Kimiko Shimizua, Shuichi Kanib, Ruud M. Buijsc, Masato Okadaa,
Katsuya Nagaia
aDivision of Protein Metabolism, Institute for Protein Research, Osaka University, 3-2 Yamada-Oka, Suita, Osaka 565-0871, Japan
bDepartment of Biochemistry, Kobe University School of Medicine, Kobe 650-0017, Japan
cNetherlands Institute for Brain Research, Meibergdreef 33, 1105 AZ Amsterdam, The Netherlands
Received 14 April 2000; received in revised form 8 June 2000
Edited by Shmuel Shaltiel
Abstract Genes differentially expressed in the subjective day
and night in the rat suprachiasmatic nucleus (SCN) were
surveyed by differential display. A gene homologous to human
casein kinase 1O (CK1O) was isolated, which initially appeared to
be expressed in the suprachiasmatic nucleus (SCN) in a circadian
manner. We here describe the cDNA cloning of the rat CK1O and
characterization of the protein products. The rCK1O is pre-
dominantly expressed in the brain including the SCN, binds and
phosphorylates mPer1, mPer2, and mPer3 in vitro, and
translocates mPer1 and mPer3, but not mPer2, to the cell
nucleus depending on its kinase activity when coexpressed with
these Per proteins in COS-7 cells. ß 2000 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
Our understanding of the molecular mechanism of mamma-
lian circadian rhythms has progressed considerably in recent
years following the discovery of the clock gene [1] and mam-
malian homologs of Drosophila clock-related genes such as
mPers and mTim [2^7]. In studies with mice: (1) mPer1, 2,
and 3 were expressed in the suprachiasmatic nucleus (SCN) in
a circadian rhythm pattern, and expression of both mPer1 and
2 was induced by light exposure [5,8] ; (2) mPer proteins in-
teracted with mCRY nuclear proteins and were translocated
into the nucleus in cultured mammalian cells transformed
with them [9]; (3) loss of the mPer2 function by deletion
mutation eliminated circadian oscillation in wheel-running ac-
tivity [10] ; and (4) double knockout of the cryptochrome gene
products mCry1 and mCry2 abolished the circadian rhythm
of wheel-running activity [11^13]. Furthermore, in Drosophila
the double-time (dbt) mutation eliminated the circadian
rhythms of Per and Tim expression, and the protein respon-
sible for the dbt mutation was shown to be a homolog of
human casein kinase 1O (hCK1O) [14,15].
To clarify the circadian oscillation mechanism, we used the
mRNA di¡erential display method to search for genes di¡er-
entially expressed in the subjective day and night in the rat
SCN and isolated the gene scop [16] and another gene homol-
ogous to human casein kinase 1O. Here, we report on the
cloning of rat casein kinase O gene and characterization of
the gene product (rCK1O).
2. Materials and methods
2.1. Animals
Male Wistar strain rats weighing 250^350 g were housed individu-
ally in plastic cages in a room maintained at 24 þ 1‡C and illuminated
for 12 h (0700^1900 h) by £uorescent light (about 80 lux). Food (type
MF; Oriental Yeast Co.) and water were freely available. The animals
were adapted to these conditions for at least 7 days prior to the
experiments.
2.2. Screening of cDNA library and sequencing
In a previous study [16], a fragment of ck1O cDNA was isolated by
the di¡erential display method. The fragment was radiolabeled with a
Multiprime Labeling kit (Amersham Pharmacia Biotech UK Ltd.,
Buckinghamshire) and used as a probe to screen a rat hypothalamic
cDNA library (Takara Biochemicals, Tokyo) according to standard
laboratory protocols for molecular cloning. DNA sequencing was
carried out using a DNA sequencing kit (Big Dye Terminator Cycle
Sequencing Ready Reaction, PE Applied Biosystems) and a genetic
analyzer (ABI 310, Perkin Elmer). cDNA fragments of mPer1, 2, and
3 were isolated as described previously [17,18].
2.3. Kinase-inactive mutant rCK1O-1
To generate a kinase-inactive form of rCK1O-1 (CK1-KN), lysine at
amino acid residue (aa) 38 was changed to arginine by polymerase
chain reaction (PCR).
2.4. Antibody
Anti-rCK1O-1 antiserum was raised against a glutathione S-trans-
ferase (GST)-rCK1O-1 fusion protein containing rCK1O-1 from aa 294
to 416. To purify anti-GST-rCK1O-1 antibody, a maltose binding
protein (MBP)-rCK1O-1 fusion protein containing the same part of
the antigen was prepared. The GST- and MBP-rCK1O-1 fusion pro-
teins were produced in Escherichia coli using pGEX (Amersham Phar-
macia Biotech) and pMAL (NEB) vectors, respectively. The MBP
fusion protein was puri¢ed using amylose resin (NEB) according to
the manufacturer’s protocol. The GST fusion protein mixed with
Freund’s complete adjuvant was used to raise the antibody in rabbits.
The resulting antiserum against GST-rCK1O-1 was subjected to a⁄n-
ity puri¢cation with the MBP fusion protein coupled to HiTrap NHS-
activated (Amersham Pharmacia Biotech).
2.5. Preparation of protein samples and immunoblot analysis
Rat organs were excised and snap-frozen in liquid nitrogen. Tissues
were homogenized in 10 volumes of TNE bu¡er containing 20 mM
Tris^HCl (pH 7.4), 1 mM EDTA, 0.15 M NaCl, 1% Nonidet P-40,
5% glycerol, 5 mM L-mercaptoethanol, 10 Wg/ml aprotinin, 10 Wg/ml
leupeptin and 1 mM phenylmethylsulfonyl £uoride. The homogenates
were centrifuged at 15 000Ug for 20 min at 4‡C. The protein concen-
tration of the supernatant (sup) fraction was determined by the Brad-
ford method. For immunoprecipitation, sup fractions prepared from
tissues or cells were incubated for 2 h at 4‡C with anti-hemagglutinin
(HA) antibody (Boehringer Mannheim) or anti-rCK1O-1 antibody
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bound to protein G-Sepharose beads. The beads were then washed
three times with TNE or RIPA lysis bu¡er and resuspended in SDS
sample bu¡er. These samples were analyzed by the immunoblot meth-
od as follows. The samples were separated on 10% SDS^PAGE gels
and transferred electrophoretically to nitrocellulose membranes. After
the transfer, the membranes were stained with Ponceau S solution to
ensure equal loading of proteins, and then blocked with 1% skim milk
in Tris-bu¡ered saline containing 0.1% Tween-20 (Tween-TBS) over-
night at 4‡C. After incubation with anti-rCK1O-1 antibody (1:5000) or
anti-HA antibody (1:2000), the membranes were incubated with
horseradish peroxidase-conjugated anti-rabbit IgG (1:5000) or mouse
IgG (1:2000) antiserum (Zymed). A chemiluminescence detection sys-
tem (NEN Life Science Products) was used for visualization. When
samples were treated with alkaline phosphatase in vitro, immunopre-
cipitated samples were subjected to dephosphorylation with calf intes-
tine alkaline phosphatase (CIP; Takara Biochemicals) for 30 min at
37‡C, washed twice with RIPA bu¡er, and resuspended in SDS sam-
ple bu¡er for the immunoblot analysis.
2.6. Immunohistochemistry
Rats were anesthetized with pentobarbital and their brains were
perfused with 50 ml saline, followed by sequential perfusion with
500 ml of 4% paraformaldehyde in phosphate bu¡er (pH 7.2), and
250 ml of 1% glutaraldehyde (pH 2.5). The brains were post-¢xed and
dehydrated in 30% sucrose in phosphate bu¡er. Brain sections with a
thickness of 20 Wm were made using a cryostat and these were im-
munohistochemically stained using anti-rCK1O-1 as described previ-
ously [19].
2.7. Cell cultures and transfection
Cultures of 293T and COS-7 cells were maintained in Dulbecco’s
modi¢ed Eagle’s medium supplemented with 10% fetal bovine serum.
For transfection experiments, cells were plated onto 100-mm culture
dishes at a density of 104 cells/cm2 and cultured for 2 days at 37‡C
under 5% CO2. After trypsinization, the cells were plated onto 6-well
plates and cultured overnight. When the culture reached 90^95% con-
£uence, the cells were transfected with expression vectors carrying
rck1O-1 cDNA (pcDNA3-rck1O-1) and HA-tagged mper cDNAs
(pHM6-mper1, 2 and 3) with LipofectAmine 2000 (Gibco BRL) ac-
cording to the manufacturer’s protocol.
2.8. Cell staining
COS-7 cells were plated onto coverslips in 35-mm culture dishes at
a density of 104 cells/cm2 and cultured overnight. For cell staining,
FuGENE 6 transfection reagent (Boehringer) was used according to
the manufacturer’s protocol. Cells were ¢xed by incubation with 4%
paraformaldehyde for 15 min at room temperature, washed twice with
phosphate-bu¡ered saline (PBS) (pH 7.4), and permeabilized by incu-
bation with 0.2% Triton X-100 in PBS for 10 min at room temper-
ature. The ¢xed cells were incubated with 120 Wl of the primary anti-
body solution (1:1000) for 2 h at room temperature in a 12-well dish,
followed by incubation with 120 Wl of a secondary antibody reagent
(Fluorolink Cy3-labeled goat anti-mouse IgG 1:2000; Alexa 488 goat
anti-rabbit IgG 1:200) for 30 min at room temperature. The stained
coverslips were mounted on a slide glass and observed under a £uo-
rescence microscope.
2.9. In vitro kinase assay
For the in vitro kinase assay of rCK1O-1, hexahistidine (His)-tagged
rCK1O-1 (His-rCK1O-1) or kinase-negative CK1-KN (His-CK1-KN)
was produced in bacteria using the pTrcHis vector (Invitrogen), and
partially puri¢ed with Ni-NTA resin (Qiagen). Prior to the reaction,
the His-rCK1O-1 was subjected to limited digestion with trypsin (15
min at 30‡C) to eliminate autophosphorylation activity, which ham-
pers the activity toward exogenous substrate. The kinase reaction was
performed in a kinase bu¡er (50 mM Tris^HCl, pH 7.4, 10 mM
MgCl2, and 1 mM L-mercaptoethanol and 50 WM [Q-32P]ATP) with
immunopuri¢ed mPer proteins or bovine milk dephosphorylated K-
casein (Sigma Chemicals) as substrates. The immunopuri¢ed mPer
proteins were treated with iodoacetamide to kill contaminated ki-
nases. After incubation for 10 min at 37‡C, the reactions were stopped
by the addition of SDS^PAGE sample bu¡er and analyzed by the
immunoblot method and autoradiography using BAS 3000 (Fuji
Film, Tokyo).
3. Results
3.1. Isolation of rCK1-O cDNA clones
We ¢rst attempted to clone a full-length cDNA for rCK1-O
from a rat hypothalamic cDNA library. Four independent
clones were obtained. Clone 1 was identical to the full-length
cDNA for rat CK1N [20]. Clone 2 contained an open reading
frame of 1248 bp encoding a protein highly homologous to
hCK1O (99.3% amino acid identity) (Fig. 1a). Thus, clone 2
appeared to encode rCK1O. Clone 3 encoded a protein iden-
tical to rCK1O except that the C-terminal 10 amino acid res-
idues of rCK1O were replaced by 100 unrelated amino acids
(Fig. 1a). The protein encoded by clone 4 was the same as
rCK1O from the initiation methionine up to aa 297, but the
remaining C-terminal portion was dissimilar to that of rCK1O
(Fig. 1a). When the C-terminal sequence of clone 4 was com-
pared with the genomic sequence of hCK1O, the clone was
found to encode a splicing variant having the seventh and
eighth exons that are spliced out in hCK1O. On the basis of
these structural features, clones 2, 3, and 4 were designated
rCK1O-1, rCK1O-2, and rCK1O-3, respectively (Fig. 1b).
rCK1O-1 was selected for functional analysis because, as noted
later, no kinase activities could be detected for rCK1O-2 and
rCK1O-3.
3.2. Distribution of rCK1O-1 protein
The tissue distribution of rCK1O-1 protein was examined by
immunoblot analysis using an antibody raised against the
Fig. 1. Three rck1O gene products. a: Alignment of amino acid se-
quences of rCK1O-1, -2 and -3. The ATP binding site and serine/
threonine kinase catalytic domain are boxed. The catalytic domain
of rCK1O is shown by arrows. b: Structures of three rCK1O iso-
forms deduced from the cDNA sequences.
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unique C-terminal sequence of rCK1O-1. Immunoreactivity at
the position corresponding to rCK1O-1 (47.3 kDa) was pre-
dominantly detected in the brain (Fig. 2a). Weak immunore-
activity was detectable in the testis and thymus. Cross-reac-
tivities to di¡erent sizes of proteins were detected in several
tissues, but their relationship to rCK1O-1 is unknown. The
distribution of rCK1O-1 protein in the adult rat brain, pineal
body and retina was investigated by immunoblot analysis
(Fig. 2b). The brain was divided into eight parts (cerebellum,
cortex, hippocampus, hypothalamus, medulla oblongata, ol-
factory bulb, SCN, and thalamus). Expression of rCK1O-1
was detected in every part of the brain and in the pineal
body and retina in similar amounts. Localization of rCK1O-
1 protein was also examined immunohistochemically ; rCK1O-
1 protein-like immunoreactivity (rCK1O-1-IR) was observed in
all regions of the brain (data not shown). When the antibody
was preabsorbed by the antigen, rCK1O-1-IR disappeared
from all brain areas. In the SCN, rCK1O-1-IR appeared to
be concentrated in nuclei of neuron-like cells. Dense CK1O-1-
IR signals were obtained for the dorsomedial region of the
middle part of the SCN (Fig. 2c-1) and the ventral and lateral
region of the rostral part (Fig. 2c-2).
3.3. rCK1O-1 phosphorylates and interacts with mPer proteins
To examine whether rCK1O phosphorylates Per proteins,
ectopic expression systems using COS-7 and 293T cells were
employed. rCK1O-1 and HA-tagged mPer1, 2, and 3 were
transiently overexpressed in these cells and the phosphoryla-
tion state of the mPer proteins was initially assessed by the
shift of electrophoretic mobility on an SDS^PAGE gel de-
tected by the immunoblot method. The data obtained using
COS-7 cells are shown in Fig. 3. The electrophoretic mobility
of each mPer markedly decreased when the active form of
rCK1O-1 (Fig. 3, lanes 4, 7, and 10), but not the KN form
(Fig. 3, lanes 5, 8, and 11), was coexpressed with mPer. When
the mPer proteins were immunoprecipitated with anti-HA
antibody, not only the active form but also the inactive
form of rCK1O-1 was coimmunoprecipitated with the mPer
proteins (Fig. 3, lanes 4, 5, 7, 8, 10, and 11), although the
mPer3 immunoprecipitate gave only a weak signal for rCK1O-
1 in COS-7 cells (Fig. 3, lanes 10 and 11). Conversely, when
rCK1O-1 was immunoprecipitated, mPer proteins were recov-
ered in the immunoprecipitates with anti-rCK1O-1 antibody,
though apparently to a lesser extent in the case of mPer1 (Fig.
3). These ¢ndings indicated that rCK1O-1 can interact directly
or indirectly with the mPer proteins independent of their
phosphorylation state, and that the most stable interaction
occurs between rCK1O-1 and mPer2. The results for 293T cells
Fig. 2. Distribution of rCK1O-1 protein. a: The tissue distribution
of rCK1O-1 protein was examined by immunoblot analysis using an
anti-rCK1O-1 antibody. In the ¢rst lane (IP), rCK1O-1 was immuno-
precipitated from the whole rat brain homogenate with anti-rCK1O-
1 antibody to show the size of rCK1O-1. The arrow and asterisk re-
spectively indicate rCK1O-1-IR and rabbit IgG. The two arrowheads
show non-speci¢c immunoreactivities. b: Distribution of rCK1O-1
protein in rat brain, pineal body and retina. The protein concentra-
tions were normalized by immunoblot analysis using an antibody
against NSE (neuron-speci¢c enolase); the results are shown in the
lower panel. c: Immunohistochemical staining of brain sections with
antibody against rCK1O-1. rCK1O-1-IR in the middle (1) and rostral
(2) parts of the SCN.
Fig. 3. rCK1O-1 phosphorylates and interacts with mPer proteins in
COS-7 cells. rCK1O-1 and HA-mPer1, 2, and 3 were transiently
overexpressed in COS-7 cells and the phosphorylation state of the
mPer proteins was assessed by the shift in the electrophoretic mobil-
ity on an SDS^PAGE gel in immunoblot analysis. Samples (TNE
lysate of COS-7 cells and its immunoprecipitates with anti-HA (IP:
KHA) or anti-rCK1O-1 (IP: KrCK1O-1) antibody) were immunoblot-
ted using anti-HA (KHA), anti-rCK1O-1 (KrCK1O-1), anti-phospho-
threonine (Kphosphothreonine) or anti-phosphoserine (Kphosphoser-
ine).
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were generally similar to those for COS-7 cells, though the
a⁄nity of the mPer proteins to interact with rCK1O-1 in 293T
cells seemed to be higher when the proteins were phosphory-
lated with the latter (data not shown). The phosphorylation of
mPer proteins in COS-7 cells was directly detected by immu-
noblotting with anti-phosphothreonine and anti-phosphoser-
ine antibodies (Fig. 3, bottom panels). The mPer proteins
were found to be phosphorylated at both threonine and serine
residues. The most prominent phosphorylation was observed
at the threonine residues of mPer2. In addition, treatment of
HA-mPer proteins, which were obtained from overexpressed
COS-7 cells and immunoprecipitated with anti-rCK1O-1 anti-
body, with alkaline phosphatase (CIP) eliminated the shifts of
the mPer proteins (Fig. 4a), which suggests the retardation
observed in the electrophoresis of the mPer proteins after
coexpression of mPer and rCK1O-1 (shown in Fig. 3) was
due to their phosphorylation (Fig. 4a).
3.4. In vitro kinase assay of rCK1O-1
To con¢rm the involvement of rCK1O-1 in the phosphory-
lation of mPer proteins, in vitro kinase assays were performed
using bacterially expressed and partially puri¢ed (with Ni-
TNA resin) His-tagged rCK1O-1. The CK1 family shares the
conserved kinase domain and has a series of variable C-ter-
minal tails. It is known that CK1O has a 123-amino acid ex-
tension beyond the kinase domain that serves as a pseudosub-
strate, inhibiting activity toward exogenous substrates [21].
Thus, prior to the assay, this His-tagged rCK1O-1 was sub-
jected to limited digestion with trypsin to eliminate the inhib-
itory C-terminal tail. Using rCK1O-1 activated by trypsin, we
Fig. 4. Gel retardation assay and in vitro kinase assay. a: HA-
tagged mPer1, 2 and 3 were immunoprecipitated with anti-HA anti-
body from COS-7 cells coexpressed with or without rCK1O-1 and
dephosphorylated by alkaline phosphatase (CIP) in vitro (lanes 3
and 6) and analyzed by the immunoblot method. The CIP treatment
inhibited gel retardation of mPer proteins. b: E¡ect of trypsin treat-
ment on casein (open circle) phosphorylation. Bacterially expressed
His-tagged rCK1O-1 (O-1) and kinase-negative rCK1O-1 (KN) were
puri¢ed, treated with trypsin, incubated with dephosphorylated K-
casein and [Q-32P]ATP in vitro, and analyzed with the immunoblot
method and autoradiography. The autophosphorylation of rCK1O-1
is showed by an arrow. c: E¡ect of trypsin treatment on phosphory-
lation of mPer proteins. Bacterially expressed His-tagged rCK1O-1
(O-1) was puri¢ed, treated with trypsin, incubated with HA-mPer
proteins immunoprecipitated with anti-HA antibody (KHA) and [Q-
32P]ATP in vitro, and analyzed by the immunoblot method and
autoradiography.
Fig. 5. E¡ects of coexpression of rCK1O-1 or kinase-negative rCK1O (rCK1OKN) with HA-mPer1 protein on the subcellular distribution of
each protein studied by immuno£uorescence cytochemistry using anti-rCK1O-1 (green) or anti-HA (red) antibody in COS-7 cells.
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examined whether it phosphorylated mPer1, 2, and 3 in vitro.
Before doing this experiment, we examined the e¡ect of the
trypsin treatment on the phosphorylation of K-casein. As seen
in Fig. 4b, before the treatment autophosphorylation of
rCK1O-1, but not phosphorylation of K-casein, was observed
(lane 1). However, after the treatment phosphorylation of K-
casein was observed (Fig. 4b, lane 3). Furthermore, when His-
CK1-KN was incubated, neither autophosphorylation nor the
phosphorylation of K-casein was observed before and after the
trypsin treatment (Fig. 4b, lanes 2 and 4). Then, we examined
the phosphorylating activity of rCK1O-1 on the HA-mPer
proteins. The full-length mPer proteins expressed in COS-7
cells were immunoprecipitated with anti-HA antibody and
used as substrates for the kinase assay. The results showed
that each mPer was phosphorylated by rCK1O-1 treated with
trypsin, but not by non-treated rCK1O-1 (Fig. 4c, lanes 4, 8,
and 12). We repeated the last experiment three times, but
could get only minute amounts of mPer proteins by immuno-
precipitation using anti-HA antibody. Therefore, we did not
succeed in determining the protein contents of mPers. Thus,
we could not calculate the stoichiometry of phosphorylations.
However, this stoichiometry study is important to give some
clue to the answer to the question whether rCK1O-1 can really
phosphorylate mPer proteins in the clock neurons in the SCN.
This must be clari¢ed in future.
3.5. CK1O-1 can translocate mPer proteins into the nucleus
Finally, the e¡ect of coexpressing rCK1O-1 with mPer pro-
teins on the subcellular distribution of each protein was
studied by immuno£uorescence cytochemistry in COS-7 cells
(Figs. 5 and 6). When rCK1O-1 and mPer proteins were in-
dependently overexpressed, almost all the immunostaining of
each protein was observed in the cytoplasm (Fig. 5), though a
faint signal for mPer1 was occasionally recognizable in the
nucleus. When mPer1 or mPer3 was coexpressed with
rCK1O-1, in both cases the majority of the immunostaining
was found in the nucleus (Figs. 5 and 6). In contrast, coex-
pression of mPer2 with rCK1O-1 did not a¡ect the cytoplasmic
distribution of either protein (Fig. 6). Furthermore, coexpres-
sion of the mPers with CK1-KN could not translocate mPer1
(Fig. 5) or mPer3 (data not shown). In any event, it appears
that the rCK1O-1 and mPer proteins always exhibit the same
localization pattern in the cells.
4. Discussion
4.1. Isolation of rCK1O and its splicing variants
When rCK1O was cloned from a rat hypothalamus cDNA
library, at least three forms of rCK1O were found to be po-
tentially expressed in the rat brain. The expression of four
alternatively spliced variants of CK1K has been reported in
chicken tissues [22,23]. However, the existence of CK1O splic-
ing variants has not hitherto been reported. Rat CK1O-1
shows 99.3% amino acid identity with hCK1O, suggesting
that it may be the dominant form of rCK1O. The CK1O iso-
forms found in this study contain an identical kinase domain
and variable C-terminal tails. Since the kinase activity of
hCK1O is known to be autoregulated by the C-terminal tail,
there are likely to be functional di¡erences among the rCK1O
variants. We attempted to verify this by comparing their sub-
strate speci¢cities. However, we have so far been unable to
detect any kinase activity for CK1O-2 and CK1O-3.
4.2. Expression of rCK1O-1 protein in the rat brain
It has previously been reported that CK1O is widely ex-
pressed in rat tissues, including the brain, testis, heart, liver,
and spleen, and that it is localized in both nuclear and cyto-
solic fractions [24]. However, we observed that the expression
of rCK1O-1 was highly restricted to the brain and was local-
ized preferentially in the nuclear fraction. A possible reason
for the apparent discrepancy could be that the CK1O detected
in the previous work [24] might have been due to cross-reac-
tivity of the antibody with a conserved region of the CK1O
family. It is noteworthy that in the brain sections examined in
the present study, rCK1O-1-IR was observed in the SCN, the
master circadian oscillator.
Fig. 6. E¡ects of coexpression of rCK1O-1 with HA-mPer2 or 3 proteins on the subcellular distribution of each protein studied by immuno£uo-
rescence cytochemistry using anti-rCK1O-1 (green) or anti-HA (red) antibody in COS-7 cells.
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4.3. rCK1O-1 protein does not appear to oscillate in the SCN
When primers speci¢c for CK1O were used to detect di¡er-
ential expression by RT-PCR, a signi¢cant though subtle dif-
ference in expression between CT6 and CT18 was discerned
(data not shown). In view of this, CK1O was at ¢rst identi¢ed
as a gene expressed in a circadian manner in the SCN. How-
ever, further analysis using a speci¢c antibody against rCK1O-
1 failed to show a signi¢cant daily change in the expression of
rCK1O-1 protein under either LD or DD conditions (data not
shown). This result was consistent with the absence of a daily
rhythm in the expression of dbt in the Drosophila head [15].
Therefore, it is more likely that the expression of rCK1O-1
does not necessarily oscillate in a circadian manner in mam-
mals.
4.4. rCK1O-1 phosphorylates and binds to mPer proteins
The transfection experiments revealed that rCK1O-1 could
be involved in the phosphorylation of mPer1, 2, and 3 in vivo
(Fig. 3). Puri¢ed rCK1O-1 was also capable of phosphorylat-
ing puri¢ed mPer proteins in vitro (Fig. 4). These ¢ndings
strongly suggest that rCK1O-1 directly phosphorylates mPer
proteins in the cells. Moreover, interaction between rCK1O-1
and the mPer proteins was clearly detected by the immuno-
precipitation assay from the cotransfected cells (Fig. 3). Since
the kinase-negative mutant of rCK1O-1 used in this experi-
ment was also able to associate with the mPer proteins to
an extent similar to that of the active rCK1O-1 in the case
of COS-7 cells (Fig. 3), it seems that the interaction is not
dependent on the phosphorylation of the mPer proteins. In
the immunoprecipitation assay, the three mPer proteins ex-
hibited some quantitative di¡erences in their interaction e⁄-
ciencies. Although a di¡erence in protein stability in the cells
may a¡ect the e⁄ciency, mPer2 appears to have the most
stable interaction with rCK1O-1. To further evaluate the in-
teraction di¡erences, competitive experiments among the
mPer proteins need to be carried out.
4.5. Nuclear translocation of mPer through phosphorylation by
rCK1O-1
When overexpressed in COS-7 cells, mPer proteins were
mainly distributed in the cytoplasm, though some nuclear
localization of mPer1 was occasionally observed (Fig. 5). Co-
expression with the active rCK1O-1, but not with the kinase-
inactive form, e⁄ciently promoted the nuclear translocation
of mPer1 and mPer3 (Figs. 5 and 6), suggesting that the phos-
phorylation of these proteins by rCK1O-1 is required for their
nuclear translocation. In the case of mPer2, however, the con-
tribution of CK1O-1 is not su⁄cient for nuclear translocation.
Complex formation with another mPer might thus be neces-
sary for mPer2 to be translocated to the nucleus. Whatever
the case, it is clear that the rCK1O-1 and mPer proteins are
always colocalized in the cells, showing the intimate relation-
ship between them.
It has been reported that mPer proteins interact with each
other, and that mPer3 can serve as a carrier of mPer1 and
mPer2 to bring them into the nucleus [9]. This nuclear entry is
supposed to be critical for the generation of circadian signals
in the SCN. However, the relationship among these mecha-
nisms, including the rCK1O-1-mediated mechanism presented
in this paper, is currently unknown.
When overexpressed in COS-7 cells, rCK1O-1 was di¡usely
distributed in the cytoplasm, which is apparently inconsistent
with the nuclear localization of rCK1O-1 observed in brain
tissue. This discrepancy can, however, be explained by the
fact that COS-7 cells lack factors required for the nuclear
localization of rCK1O-1, such as mPer1 and mPer2. In this
regard, it can be hypothesized that mPer1 and mPer3 could
serve as carriers of rCK1O-1 into the nucleus. The classical
functions of CK1O include the regulation of DNA replication,
DNA repair, and nuclear tra⁄cking, all of which are related
to nuclear functions [25^28]. It is therefore possible that
mPer1 and/or mPer3 is involved in the mammalian circadian
rhythm mechanism through regulating the function of rCK1O-
1.
4.6. rCK1O-1 as a component of the mammalian circadian clock
In this study, we have presented a line of evidence support-
ing the proposition that rCK1O-1 phosphorylates mPer pro-
teins and promotes the nuclear translocation of at least mPer1
and mPer3. Currently, the basic system of the mammalian
circadian clock is thought to involve a negative feedback
loop comprised of the following steps: (1) activation of
mPer and mCry expression by the CLOCK-BMAL1 complex
through the E-boxes of the promoter regions of the mper and
mcry genes; (2) accumulation of mPer and mCry proteins in
the cytoplasm; (3) nuclear translocation of mPer and mCry
proteins; and (4) inhibition of the CLOCK-BMAL1 function
by mPer, mCry, or an mPer^mCry complex [9]. In this loop,
rCK1O-1 may be located upstream of the nuclear entry of
mPer. To determine whether this is the case, loss-of-function
and gain-of-function studies in the mammalian system will
have to be conducted.
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